| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.7M | +1.5% |
| Cost of Revenue | $29.8M | +4.8% |
| R&D Expense | $12.2M | +5.8% |
| SG&A Expense | $31.8M | -4.5% |
| Operating Income | $19.7M | +3.9% |
| Pre-tax Income | $21.4M | +7.0% |
| Income Tax | $5.6M | +9.7% |
| Net Income | $15.9M | +6.1% |
| EPS (Basic) | $0.77 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.3M | -13.3% |
| Accounts Receivable | $22.6M | +3.2% |
| Current Assets | $57.9M | -5.6% |
| Total Assets | $206.1M | -5.1% |
| Current Liabilities | $49.1M | +0.7% |
| Total Liabilities | $59.7M | -4.2% |
| Stockholders' Equity | $146.4M | -5.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.9M | +0.1% |
| Capital Expenditures | $3.8M | +17.0% |
| Investing Cash Flow | -$3.1M | +4.9% |
| Financing Cash Flow | -$29.8M | -4.4% |
| Free Cash Flow | $25.2M | -2.0% |
| +4.1% |
| EPS (Diluted) | $0.75 | +2.7% |